CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

In the longer term, CVS stock is down nearly 30% on a YTD basis, underperforming XHS’ 8% gain. Moreover, shares of CVS have dipped 24.8% over the past 52 weeks, compared to XHS’ 11.6% return ...

CVS Health (CVS) ended the recent trading session at $66.60, demonstrating a -4.28% change from the preceding day's closing price. This change lagged the S&P 500's 0.48% gain on the day. Meanwhile, ...

Shares of CVS Health Corp. slipped 4.28% to $66.60 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.47% to 6,227.42 and the Dow ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

Shares of CVS Health Corp. CVS advanced 2.67% to $68.14 Thursday, on what proved to be an all-around great trading session ...

CVS Health's issues didn't start in 2024, though, and that's the problem for the healthcare giant. It's much harder to ignore more than two years of poor performance. What exactly is going on with ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. ... Truist expects better operational performance, ... CVS stock is up 5.77% at $66.97 at the last check on Thursday.

CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January ...

However, CVS Health's corporate update on Tuesday was likely a factor behind the stock's jump, too. CVS Health announced that Brian Newman will be the new CFO effective April 21, 2025.